Researchers at Northeastern University have developed a synthetic cannabinoid compound that replicates the therapeutic effects of cannabis-derived molecules without producing the psychoactive effects associated with THC. The compound selectively targets cannabinoid receptors involved in pain modulation and inflammation while avoiding those linked to cognitive impairment and intoxication. In early laboratory testing, the synthetic molecule demonstrated strong potential for treating chronic pain and inflammatory conditions, offering a possible alternative to both opioid medications and traditional cannabis-based therapies. The discovery could help overcome regulatory, medical, and safety concerns that have limited widespread clinical use of cannabinoids, while still leveraging their biological benefits. Researchers emphasize that further testing is required, but the work represents a promising step toward safer cannabinoid-based medicines.
Source:
Northeastern University
Link:
https://news.northeastern.edu/2025/12/16/synthetic-cannabinoid-discovery/
Leave a Reply